G蛋白结合受体87 (GPR87) 在末期脏和相关瘤中
Tamas Beothe1, Gyula Kovacs2,3, Lehel Peterfi4
1Department of Urology, Peterfy Sandor Hospital, Budapest, Hungary.
Anticancer research
|February 2, 2024
概括
在末期病 (ESRD) 和获得性囊性病 (ACRD) 中,GPR87信号传递对重塑和癌症发展至关重要. 这项研究突出了GPR87的重点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 末期病 (ESRD) 和获得性囊性病 (ACRD) 涉及炎症,结构变化和独特的癌症.
- 在ACRD脏中,只会出现埃索诺菲尔真空化和染色恐惧性细胞癌.
研究的目的:
- 研究ESRD和ACRD中驱动致癌的分子机制.
- 分析GPR87在ESRD/ACRD相关癌发展中的作用.
主要方法:
- 使用PCR,RT-PCR和免疫组织化学来评估GPR87的表达.
- 检查了正常脏,ESRD/ACRD脏和相关瘤中的GPR87表达.
主要成果:
- 在ESRD/ACRD脏中,GPR87的表达很高,并且在ESRD/ACRD脏中表达特别.
- 在ESRD/ACRD脏的增殖表皮细胞中观察到强烈的GPR87表达.
- 在ACRD相关的细胞癌细胞中也表达了GPR87.
结论:
- GPR87信号是ESRD/ACRD脏结构重塑的组成部分.
- 在独特的ACRD相关瘤的发展中,GPR87起着重要作用.
- 针对GPR87可能为与ACRD相关的癌提供治疗策略.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
577
07:56Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
Published on: January 17, 2012
28.7K
相关概念视频
G Protein-coupled Receptors
12.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Endocrine Signaling
64.3K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
64.3K
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
Transducer Mechanism: G Protein–Coupled Receptors
2.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.0K
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
